A Multifaceted Approach

Close this search box.


The main purpose, function, and cell targeting of Vedicinals 9 is as follows:


Vedicinals®9 is a herbal formulation aimed at addressing the pathophysiological issues associated with Long COVID, Spikeopathy, and other viral infections like COVID-19. It targets viral replication and aids in the recovery phase from these viral infections.


Vedicinals®9 contains a blend of bioactive compounds: baicalin, quercetin, luteolin, rutin, hesperidin, curcumin, EGCG, piperine, and glycyrrhizin.

These ingredients were carefully selected for their ability to inhibit viral replication, reduce inflammation, and support the body’s recovery process.

Vedicinals®9 has shown efficacy in treating COVID-19, Long COVID, and other viral illnesses by addressing issues like the cancer-causing potential of SARS-CoV-2, immunodeficiency, and neuroinflammation.

Cell Targeting:

Vedicinals®9 targets various cells and pathways affected by SARS-CoV-2 and other viral infections, including:

  • Inhibiting viral replication in host cells
  • Reducing inflammation and oxidative stress in affected tissues
  • Protecting neuronal and glial cells from damage in the central nervous system
  • Enhancing the body’s immune response and recovery mechanisms


The main purpose of Vedicinals®9 is to support the recovery from Long COVID, Spikeopathy, and other viral infections by targeting multiple pathways and cell types affected by these conditions through its unique blend of herbal ingredients.

Overall, Vedicinals®9 offers a holistic approach to meeting nutritional needs while prioritizing safety, quality, and convenience.

The Core Benefits from Treatment with Vedicinals®9

Vedicinals®9 offers a range of benefits.

Here are the key points:

  • Shows a 75% reduction in inflammatory markers, aiding in the recovery from acute and long-term COVID conditions.
  • Demonstrates a 70% improvement in cardiac and cardio/thrombotic markers, supporting heart health.
  • Offers noticeable reductions in symptoms such as fatigue, shortness of breath, hypoxia, sore throat, inflammation, myalgia, heart damage, and overall viral clearance time.
  •  A two-week treatment with Vedicinals®9 showed a 71% improvement in lung damage measures.
  •  Upon starting treatment, 58% of patients were discharged from the hospital within the first week, and 75% of patients tested negative for COVID within the first week.
  •  Approved as a food supplement cum Nutraceutical, FSMP by the Food Safety And Standards Authority of India (FSSAI), indicating safety and efficacy.
  • The combination of bioactive molecules in Vedicinals®9 supports overall health improvement, which can indirectly benefit mental well-being by reducing stress and improving physical health.

These benefits highlight Vedicinals®9’s potential in supporting both physical health and mental well-being, especially in the context of recovery from COVID-19 and its long-term effects via Spike removal.

Vedicinals®9 Whitepaper & Studies

Shopping Cart